Results 71 to 80 of about 112,556 (314)

Correlation of Interleukin-10 and Interleukin-8 with Cytomegalovirus and Epstein–Barr Virus Infection in Hemodialysis Patients

Medical Journal of Babylon
Background: Herpes viruses like cytomegalovirus (CMV) and Epstein–Barr virus (EBV) can cause serious illness in those who already have impaired immune systems. Objectives: The purpose of this research was to examine the impact of CMV and EBV infection on
Eman Ammar Ihsan, Lezan Medhat Mohammed, Waleed Mohammed Ali   +2 more
doaj   +1 more source

EBV-specific T cell responses in long-term kidney transplant recipients (KTRs) and healthy controls (HCs).

, 2019
(A) Polyfunctionality profile of latent (responders, KTRs n = 3/5; HCs n = 4/5) and lytic (responders, KTRs n = 8/10; HCs n = 13/15) EBV-specific CD4+ T cells from responding KTRs and HCs, displaying each possible combination of cytokine (IFNγ, IL-2 ...
Sylvain Choquet (7526123), Nadia Arzouk (7526120), Sonia Burrel (7526126), Amélie Guihot (221393), Martin Larsen (147164), Vincent Vieillard (186338), Nicolas Gauthier (431233), Brigitte Autran (79073), Nadine Tarantino (458066), Cecilia Nakid-Cordero (7526117)   +9 more
core   +1 more source

A descriptive case series of hepatotoxicity associated with CFTR modulators and possible relevance of pharmacogenetic polymorphisms in cystic fibrosis patients

British Journal of Clinical Pharmacology, EarlyView.
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are widely used in patients with cystic fibrosis and significantly improve respiratory function and quality of life. However, their effectiveness may be limited by liver damage, which sometimes leads to treatment discontinuation, and the mechanisms underlying this remain poorly ...
Clara Laffitte Redondo, Venceslas Bourdin, Abd El Kader Ait Tayeb, Sihem Benaboud, Inès Martins, Caroline Joyau, Myriam Benhamida, Isabelle Sermet‐Gaudelus, Clémence Martin, Pierre Régis Burgel, Céline Verstuyft, Laurent Chouchana, Estelle Ayme‐Dietrich   +12 more
wiley   +1 more source

Ulcerative Manifestations of Hodgkin’s Lymphoma: A Rare Presentation and Its Diagnostic Challenges

Indian Journal of Dermatopathology and Diagnostic Dermatology
Ulceration as cutaneous presentation of Hodgkin lymphoma (HL) is rare and needs to be differentiated from other dermatological or systemic conditions that present with chronic non-healing ulcers. Although the overall prognosis of Hodgkin lymphoma (HL) is
Shreya Singh, Ketki S. Bhoite, Swati Prasanna   +2 more
doaj   +1 more source

EBV-miR-BART1-5P directly targets cellular AMPKα1 gene.

, 2018
(A) EBV-miR-BART1-5P and its putative binding sequences in the 3’UTR of AMPKα1. Mutation was generated in the complementary site that binds to the seed region of BV-miR-BART1-5P.
Jianguo Wang (1400488), Xin Li (51274), Qiang Jiang (764314), Yufei Long (6091580), Xu Yang (112496), Tielian Liu (6091577), Jing Huang (41604), Chi Man Tsang (155945), Gongfa Wu (6091571), Qian Wang (32718), Tuotuo Chong (6091583), Sai Wah Tsao (123629), Pengfei Liu (136115), Oluwasijibomi Damola Faleti (6091574), Yang Jiao (147576), Xiaoming Lyu (417710), Xia Guo (486444), Mingliang He (2831675)   +17 more
core   +1 more source

Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With SQSTM1::ALK Fusion

Diagnostic Cytopathology, EarlyView.
ABSTRACT Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare and aggressive variant of inflammatory myofibroblastic tumor (IMT) characterized by epithelioid morphology, atypical features, ALK rearrangements, and early metastatic potential.
Havva Gokce Terzioglu, Phillip McMullen, Güliz A. Barkan   +2 more
wiley   +1 more source

EBV-miR-BART1-5P induces angiogenesis in vitro and vivo.

, 2018
(A, C) Tube formation potential of HUVEC cells following the exposure to conditioned media collected from NPC cells treated with EBV-miR-BART1-5P or anti-miR. (B, D) CAM angiogenesis was performed with NPC cells overexpressing or inhibiting EBV-miR-BART1-
Jianguo Wang (1400488), Xin Li (51274), Qiang Jiang (764314), Yufei Long (6091580), Xu Yang (112496), Tielian Liu (6091577), Jing Huang (41604), Chi Man Tsang (155945), Gongfa Wu (6091571), Qian Wang (32718), Tuotuo Chong (6091583), Sai Wah Tsao (123629), Pengfei Liu (136115), Oluwasijibomi Damola Faleti (6091574), Yang Jiao (147576), Xiaoming Lyu (417710), Xia Guo (486444), Mingliang He (2831675)   +17 more
core   +1 more source

Relationship of the recurrence after pterygium surgery with the presence of HSV, EBV, CMV, HPV, and BRAFV600E mutation

Journal of Ophthalmology, 2019
Background: Previously, we have reported on associations of pterygium with the presence of herpes simplex virus (HSV), Epstein Barr virus (EBV), cytomegalovirus (CMV), human papillomavirus (HPV), and the BRAFV600E somatic point.
S.O. Rykov, K.O Usenko, S.Iu. Mogilevskyy, S.V. Ziablitsev, L.I. Denisiuk   +4 more
doaj   +1 more source

Two Oncoviruses of HPV and EBV in Breast Cancer: An Iran-based Study

JLUMHS, 2023
OBJECTIVE: To answer the question of whether viral infections such as Human papillomavirus (HPV) and Epstein-Barr virus (EBV) are involved in the occurrence of breast cancer or not.
Mona Fani, Riam Sadooni, Mahmoud Haghighat Nejad, Neda Naseri Mirzavieh, Sara Mobarak, Reza Pakzad, Yousef Erfani, Shokrollah Salmanzadeh, Samaneh Abbasi   +8 more
doaj   +1 more source

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19‐09, CONPELAN Study

Head &Neck, EarlyView.
ABSTRACT Background The benefit of consolidation programmed cell death protein 1 (PD‐1) blockade after chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. Methods Patients with stages II–IVB NPC were randomized (2:1) to pembrolizumab 200 mg or placebo every 3 weeks for up to 17 cycles after chemoradiotherapy ...
Sang Hoon Chun, Seyoung Seo, Jang Ho Cho, Keon‐Uk Park, Sang‐Cheol Lee, Yong Won Choi, Tak Yun, Seong Hoon Shin, Sung‐Bae Kim, Seungeun Lee, Chang Ho Ahn, Bhumsuk Keam   +11 more
wiley   +1 more source